Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,437 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Recruiting

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

NCT06216301

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Western Regional Medical Center, LLC Goodyear, Arizona, United States
  • St. Jude Herritage Medical Group Fullerton, California, United States
  • Hoag Family Cancer Institute - Hoag Memorial Hospital Newport Beach, California, United States
View all 98 locations
View Trial Details
Recruiting

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

NCT06500455

Conditions
Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, +52 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 270 locations
View Trial Details
Recruiting

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

NCT06952010

Conditions
Advanced Solid Tumor, Immune Sensitive Tumor, Metastatic Solid Tumor, +6 more
Locations
  • Exelixis Clinical Site #5 San Francisco, California, United States
  • Exelixis Clinical Site #4 New Haven, Connecticut, United States
  • Exelixis Clinical Site #8 Tampa, Florida, United States
  • Exelixis Clinical Site #10 Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

NCT07046923

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +28 more
Locations
  • Stanford Medicine Cancer Center Stanford, California, United States
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
View all 27 locations
View Trial Details
Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT06625775

Conditions
Advanced Breast Cancer, Advanced Lung Cancer, Breast Diseases, +35 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 40 locations
View Trial Details
Recruiting

KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II

NCT05525858

Conditions
Advanced Solid Tumor, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations
  • Soonchunhyang University Hospital Bucheon Bucheon-si, South Korea
  • Chungbuk National University Hospital Chungju, South Korea
  • Keimyung University Dongsan Hospital Daegu, South Korea
  • Kyungpook National University Chilgok Hospital Daegu, South Korea
View all 32 locations
View Trial Details
Recruiting

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

NCT05614739

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
Locations
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) - Division of Hematology-Oncology Los Angeles, California, United States
  • University of California - Irvine Orange, California, United States
View all 82 locations
View Trial Details

Related conditions